| Tretinoin | Approved Investigational Nutraceutical | HIP1 | 3092 |
downregulated | Tretinoin results in decreased expression of HIP1 mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | HIPK1 | 204851 |
downregulated | Tretinoin results in decreased expression of HIPK1 mRNA | 1p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIPK2 | 28996 |
upregulated | Tretinoin results in increased expression of HIPK2 mRNA | 7q34 | |
| Tretinoin | Approved Investigational Nutraceutical | HIPK3 | 10114 |
upregulated | Tretinoin results in increased expression of HIPK3 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | HIRA | 7290 |
downregulated | Tretinoin results in decreased expression of HIRA mRNA | 22q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST1H1C | 3006 |
upregulated | Tretinoin results in increased expression of HIST1H1C mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST1H1D | 3007 |
downregulated | Tretinoin results in decreased expression of HIST1H1D mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST1H2AC | 8334 |
downregulated | Tretinoin results in decreased expression of HIST1H2AC mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST1H2BD | 3017 |
downregulated | Tretinoin results in decreased expression of HIST1H2BD mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST1H2BE | 8344 |
downregulated | Tretinoin results in decreased expression of HIST1H2BE mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST1H2BH | 8345 |
downregulated | Tretinoin results in decreased expression of HIST1H2BH mRNA | 6p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST1H2BK | 85236 |
downregulated | Tretinoin results in decreased expression of HIST1H2BK mRNA | 6p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST2H2AA3 | 8337 |
upregulated | Tretinoin results in increased expression of HIST2H2AA3 mRNA | 1q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIST2H2BE | 8349 |
upregulated | Tretinoin results in increased expression of HIST2H2BE mRNA | 1q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIVEP2 | 3097 |
upregulated | Tretinoin results in increased expression of HIVEP2 mRNA | 6q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HIVEP3 | 59269 |
upregulated | Tretinoin results in increased expression of HIVEP3 mRNA | 1p34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HJURP | 55355 |
downregulated | Tretinoin results in decreased expression of HJURP mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HK2 | 3099 |
downregulated | Tretinoin results in decreased expression of HK2 mRNA | 2p12 | |
| Tretinoin | Approved Investigational Nutraceutical | HK2P1 | 642546 |
downregulated | Tretinoin results in decreased expression of HK2P1 mRNA | Xq21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HK3 | 3101 |
upregulated | Tretinoin results in increased expression of HK3 mRNA | 5q35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HLA-B | 3106 |
upregulated | Tretinoin results in increased expression of HLA-B mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | HLA-C | 3107 |
upregulated | Tretinoin results in increased expression of HLA-C mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | HLA-DQB1 | 3119 |
upregulated | Tretinoin results in increased expression of HLA-DQB1 mRNA | 6p21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HLA-E | 3133 |
upregulated | Tretinoin results in increased expression of HLA-E mRNA | 6p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HLA-F | 3134 |
upregulated | Tretinoin results in increased expression of HLA-F mRNA | 6p22.1 | |